# Relationship Between Maternal Soluble Trigger Receptor Expressed on Myeloid Cells-1 (sTREM-1) and Placenta Accreta Spectrum

> **NCT05376410** · — · UNKNOWN · sponsor: **Necmettin Erbakan University** · enrollment: 90 (estimated)

## Conditions studied

- Placenta Accreta, Third Trimester

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05376410
- **Lead sponsor:** Necmettin Erbakan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-14
- **Primary completion:** 2022-06-01
- **Final completion:** 2022-07-01
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2022-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05376410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05376410, "Relationship Between Maternal Soluble Trigger Receptor Expressed on Myeloid Cells-1 (sTREM-1) and Placenta Accreta Spectrum". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05376410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*